The ExOne Co. (XONE) Director Sells $77,550.00 in Stock
The ExOne Co. (NASDAQ:XONE) Director John Irvin sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, October 3rd. The shares were sold at an average price of $15.51, for a total value of $77,550.00. Following the completion of the transaction, the director now owns 154,300 shares in the company, valued at approximately $2,393,193. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Shares of The ExOne Co. (NASDAQ:XONE) opened at 15.84 on Thursday. The firm’s market cap is $254.50 million. The ExOne Co. has a 1-year low of $6.50 and a 1-year high of $16.15. The firm’s 50-day moving average price is $14.21 and its 200 day moving average price is $12.04.
The ExOne (NASDAQ:XONE) last announced its quarterly earnings results on Tuesday, August 9th. The company reported ($0.18) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.27) by $0.09. The business had revenue of $11.80 million for the quarter, compared to analyst estimates of $11.12 million. The ExOne had a negative return on equity of 16.30% and a negative net margin of 43.59%. The company’s quarterly revenue was up 38.8% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.48) EPS. On average, equities research analysts forecast that The ExOne Co. will post ($0.72) EPS for the current fiscal year.
XONE has been the subject of several recent research reports. FBR & Co reaffirmed an “outperform” rating and issued a $18.00 price target on shares of The ExOne in a report on Monday. Zacks Investment Research cut The ExOne from a “buy” rating to a “hold” rating in a report on Saturday, August 27th. Brean Capital reaffirmed a “hold” rating on shares of The ExOne in a report on Thursday, August 11th. Finally, Canaccord Genuity reaffirmed a “hold” rating and issued a $12.00 price target on shares of The ExOne in a report on Wednesday, August 10th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. The ExOne has a consensus rating of “Hold” and a consensus price target of $13.60.
Large investors have recently made changes to their positions in the company. Marathon Capital Management purchased a new stake in shares of The ExOne during the second quarter valued at approximately $106,000. Sanders Morris Harris Inc. purchased a new stake in shares of The ExOne during the second quarter valued at approximately $124,000. Parametric Portfolio Associates LLC raised its stake in shares of The ExOne by 4.4% in the second quarter. Parametric Portfolio Associates LLC now owns 12,078 shares of the company’s stock valued at $128,000 after buying an additional 507 shares during the period. A.R.T. Advisors LLC purchased a new stake in shares of The ExOne during the second quarter valued at approximately $150,000. Finally, Commerzbank Aktiengesellschaft FI raised its stake in shares of The ExOne by 4.3% in the second quarter. Commerzbank Aktiengesellschaft FI now owns 16,886 shares of the company’s stock valued at $178,000 after buying an additional 698 shares during the period. 16.00% of the stock is currently owned by institutional investors and hedge funds.
The ExOne Company Profile
The ExOne Company is a provider of three dimensional (3D) printing machines and 3D printed and other products, materials and services to industrial customers. The Company’s business primarily consists of manufacturing and selling 3D printing machines and printing products to specification for its customers using its installed base of 3D printing machines.
Receive News & Stock Ratings for The ExOne Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The ExOne Co. and related stocks with our FREE daily email newsletter.